Black Rock Inc. Y M Abs Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,938,718 shares of YMAB stock, worth $24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,938,718

Previous 2,857,257 2.85%

Holding current value

$24 Million

Previous $46.5 Million 23.59%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$11.6 - $17.25 $944,947 - $1.41 Million	81,461 Added 2.85%	2,938,718 $35.5 Million
Q1 2024 May 10, 2024	SELL	$6.57 - $18.69 $393,037 - $1.12 Million	-59,823 Reduced 2.05%	2,857,257 $46.5 Million
Q4 2023 Feb 13, 2024	BUY	$4.88 - $7.42 $2.17 Million - $3.29 Million	443,724 Added 17.94%	2,917,080 $19.9 Million
Q3 2023 Nov 13, 2023	SELL	$4.86 - $7.23 $283,935 - $422,398	-58,423 Reduced 2.31%	2,473,356 $13.5 Million
Q2 2023 Aug 11, 2023	BUY	$5.68 - $10.34 $969,496 - $1.76 Million	170,686 Added 7.23%	2,531,779 $17.2 Million
Q1 2023 May 12, 2023	SELL	$2.83 - $5.11 $616,042 - $1.11 Million	-217,683 Reduced 8.44%	2,361,093 $11.8 Million
Q4 2022 Feb 13, 2023	SELL	$3.0 - $15.17 $955,854 - $4.83 Million	-318,618 Reduced 11.0%	2,578,776 $12.6 Million
Q3 2022 Nov 14, 2022	SELL	$13.96 - $19.67 $1.1 Million - $1.55 Million	-78,827 Reduced 2.65%	2,897,394 $41.8 Million
Q2 2022 Aug 12, 2022	BUY	$8.22 - $15.13 $255,863 - $470,951	31,127 Added 1.06%	2,976,221 $45 Million
Q1 2022 May 12, 2022	BUY	$6.55 - $17.42 $1.16 Million - $3.1 Million	177,734 Added 6.42%	2,945,094 $35 Million
Q4 2021 Feb 10, 2022	BUY	$15.51 - $29.31 $473,055 - $893,955	30,500 Added 1.11%	2,767,360 $44.9 Million
Q3 2021 Nov 09, 2021	BUY	$27.47 - $37.31 $911,152 - $1.24 Million	33,169 Added 1.23%	2,736,860 $78.1 Million
Q2 2021 Aug 11, 2021	BUY	$25.45 - $37.64 $68.8 Million - $102 Million	2,703,691 New	2,703,691 $91.4 Million

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account